{"id":214,"date":"2017-01-01T10:59:31","date_gmt":"2017-01-01T10:59:31","guid":{"rendered":"https:\/\/www-menarah-org.kentuniresestg.wpengine.com\/?p=214"},"modified":"2024-01-08T09:59:24","modified_gmt":"2024-01-08T09:59:24","slug":"elevated-serum-%ce%b1-synuclein-autoantibodies-in-patients-with-parkinsons-disease-relative-to-alzheimers-disease-and-controls","status":"publish","type":"post","link":"https:\/\/menarah.org\/ar\/elevated-serum-%ce%b1-synuclein-autoantibodies-in-patients-with-parkinsons-disease-relative-to-alzheimers-disease-and-controls\/","title":{"rendered":"\u0627\u0631\u062a\u0641\u0627\u0639 \u0627\u0644\u0623\u062c\u0633\u0627\u0645 \u0627\u0644\u0645\u0636\u0627\u062f\u0629 \u03b1-\u0633\u064a\u0646\u0648\u0643\u0644\u064a\u0646 \u0641\u064a \u0627\u0644\u0645\u0631\u0636\u0649 \u0627\u0644\u0630\u064a\u0646 \u064a\u0639\u0627\u0646\u0648\u0646 \u0645\u0646 \u0645\u0631\u0636 \u0628\u0627\u0631\u0643\u0646\u0633\u0648\u0646"},"content":{"rendered":"

\u064a\u0639\u062f \u0627\u0644\u062a\u0634\u062e\u064a\u0635 \u0627\u0644\u0645\u0628\u0643\u0631 \u0644\u0644\u0623\u0645\u0631\u0627\u0636 \u0627\u0644\u062a\u0646\u0643\u0633\u064a\u0629 \u0627\u0644\u0639\u0635\u0628\u064a\u0629 \u0630\u0627 \u0623\u0647\u0645\u064a\u0629 \u0642\u0635\u0648\u0649 \u0644\u0646\u062c\u0627\u062d \u0627\u0644\u0639\u0644\u0627\u062c. \u064a\u0639\u062f \u0627\u0644\u0627\u0641\u062a\u0642\u0627\u0631 \u0625\u0644\u0649 \u0627\u0644\u0645\u0624\u0634\u0631\u0627\u062a \u0627\u0644\u062d\u064a\u0648\u064a\u0629 \u0627\u0644\u062d\u0633\u0627\u0633\u0629 \u0648\u0627\u0644\u0645\u0628\u0643\u0631\u0629 \u0644\u062a\u0634\u062e\u064a\u0635 \u0623\u0645\u0631\u0627\u0636 \u0645\u062b\u0644 \u0645\u0631\u0636 \u0628\u0627\u0631\u0643\u0646\u0633\u0648\u0646 (PD) \u0645\u0634\u0643\u0644\u0629 \u0645\u0639\u064a\u0642\u0629 \u0644\u062c\u0645\u064a\u0639 \u0627\u0644\u0645\u062a\u062e\u0635\u0635\u064a\u0646 \u0641\u064a \u0627\u0636\u0637\u0631\u0627\u0628\u0627\u062a \u0627\u0644\u062d\u0631\u0643\u0629. \u064a\u0639\u062f \u0627\u0633\u062a\u062e\u062f\u0627\u0645 \u0627\u0644\u0623\u062c\u0633\u0627\u0645 \u0627\u0644\u0645\u0636\u0627\u062f\u0629 \u0627\u0644\u0645\u0646\u0627\u0639\u064a\u0629 \u0627\u0644\u0630\u0627\u062a\u064a\u0629 \u0641\u064a \u0627\u0644\u062f\u0645 (AIAs) \u0636\u062f \u0627\u0644\u0628\u0631\u0648\u062a\u064a\u0646\u0627\u062a \u0627\u0644\u0639\u0635\u0628\u064a\u0629 \u0627\u0633\u062a\u0631\u0627\u062a\u064a\u062c\u064a\u0629 \u0648\u0627\u0639\u062f\u0629 \u062c\u062f\u064a\u062f\u0629 \u0644\u062a\u0634\u062e\u064a\u0635 \u0627\u0636\u0637\u0631\u0627\u0628\u0627\u062a \u0627\u0644\u062f\u0645\u0627\u063a \u0645\u0646 \u062e\u0644\u0627\u0644 \u0637\u0631\u064a\u0642\u0629 \u063a\u064a\u0631 \u062c\u0631\u0627\u062d\u064a\u0629 \u0648\u0641\u0639\u0627\u0644\u0629 \u0645\u0646 \u062d\u064a\u062b \u0627\u0644\u062a\u0643\u0644\u0641\u0629. \u0641\u064a \u0647\u0630\u0647 \u0627\u0644\u062f\u0631\u0627\u0633\u0629\u060c \u0642\u0645\u0646\u0627 \u0628\u0642\u064a\u0627\u0633 \u0645\u0633\u062a\u0648\u0649 AIAs \u0636\u062f \u03b1-synuclein (\u03b1-syn)\u060c \u0648\u0647\u0648 \u0628\u0631\u0648\u062a\u064a\u0646 \u0645\u0647\u0645 \u064a\u0634\u0627\u0631\u0643 \u0641\u064a \u0627\u0644\u062a\u0633\u0628\u0628 \u0641\u064a PD. \u0641\u064a \u062f\u0631\u0627\u0633\u062a\u0646\u0627 \u062a\u0645 \u062a\u0642\u064a\u064a\u0645 \u0627\u0644\u0645\u0631\u0636\u0649 \u0627\u0644\u0630\u064a\u0646 \u064a\u0639\u0627\u0646\u0648\u0646 \u0645\u0646 PD (46 \u0645\u0631\u064a\u0636\u0627)\u060c \u0648\u0645\u0631\u0636 \u0627\u0644\u0632\u0647\u0627\u064a\u0645\u0631 (AD) (27 \u0645\u0631\u064a\u0636\u0627) \u0648\u0627\u0644\u0636\u0648\u0627\u0628\u0637 \u0627\u0644\u0635\u062d\u064a\u0629 (20 \u0645\u0631\u064a\u0636\u0627) \u0648\u0641\u0642\u0627 \u0644\u0645\u0633\u062a\u0648\u064a\u0627\u062a AIAs \u0627\u0644\u0623\u0645\u0635\u0627\u0644 \u03b1-syn. \u0648\u0645\u0646 \u0627\u0644\u0645\u062b\u064a\u0631 \u0644\u0644\u0627\u0647\u062a\u0645\u0627\u0645 \u0623\u0646 \u03b1-syn AIAs \u0643\u0627\u0646\u062a \u0645\u0631\u062a\u0641\u0639\u0629 \u0628\u0634\u0643\u0644 \u0645\u0644\u062d\u0648\u0638 \u0641\u064a \u0645\u062c\u0645\u0648\u0639\u0629 PD \u0645\u0642\u0627\u0631\u0646\u0629 \u0628\u0640 AD \u0648\u0627\u0644\u0636\u0648\u0627\u0628\u0637 \u0627\u0644\u0635\u062d\u064a\u0629\u060c \u0645\u0645\u0627 \u064a\u062f\u0639\u0648 \u0625\u0644\u0649 \u0627\u0633\u062a\u062e\u062f\u0627\u0645\u0647\u0627 \u0644\u062a\u0634\u062e\u064a\u0635 PD.<\/p>\n\n\n\n

\u0634\u0644\u0627\u0634 \u0623\u060c \u0633\u0644\u0627\u0645\u0629<\/a><\/strong> \u0645\u060c \u0645\u0643\u0627\u0631 \u0645\u060c \u0631\u0634\u062f\u064a \u062a\u060c \u0627\u0644\u0631\u0635\u0627\u0635<\/a> \u062d \u062d\u060c \u0645\u062d\u0645\u062f<\/a>\u0648\u0645\u060c \u0627\u0644\u0628\u0644\u0642\u064a\u0645\u064a \u062d\u060c \u0627\u0628\u0648 \u062f\u0646\u064a\u0627<\/a> \u0645\u064a\u063a\u0627\u0628\u0627\u064a\u062a.2017.  \u0627\u0631\u062a\u0641\u0627\u0639 \u0627\u0644\u0623\u062c\u0633\u0627\u0645 \u0627\u0644\u0645\u0636\u0627\u062f\u0629 \u0623\u0644\u0641\u0627 \u0633\u064a\u0646\u0648\u0643\u0644\u064a\u0646 \u0641\u064a \u0645\u0635\u0644 \u0627\u0644\u0645\u0631\u0636\u0649 \u0627\u0644\u0630\u064a\u0646 \u064a\u0639\u0627\u0646\u0648\u0646 \u0645\u0646 \u0645\u0631\u0636 \u0628\u0627\u0631\u0643\u0646\u0633\u0648\u0646 \u0645\u0642\u0627\u0631\u0646\u0629 \u0628\u0645\u0631\u0636 \u0627\u0644\u0632\u0647\u0627\u064a\u0645\u0631 \u0648\u0627\u0644\u0636\u0648\u0627\u0628\u0637<\/a>. \u0623\u0645\u0627\u0645. \u0646\u064a\u0648\u0631\u0648\u0644. 8:720| \u062f\u0648\u0649: 10.3389.<\/p>","protected":false},"excerpt":{"rendered":"

Early diagnosis of neurodegenerative diseases is of paramount importance for successful treatment. Lack of sensitive and early biomarkers for diagnosis of diseases like Parkinson\u2019s disease (PD) is a handicapping problem for all movement disorders specialists. Using serum autoimmune antibodies (AIAs) against neural proteins is a new promising strategy to diagnose brain disorders through non-invasive and […]<\/p>\n","protected":false},"author":13,"featured_media":383,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5,17],"tags":[23,33,45,61,95],"class_list":{"0":"post-214","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-international_learning","8":"category-publications","9":"tag-23","10":"tag-ageing","11":"tag-dementia","12":"tag-health","13":"tag-research"},"yoast_head":"\nElevated Serum \u03b1-Synuclein Autoantibodies in Patients with Parkinson\u2019s Disease - Menarah<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/menarah.org\/ar\/elevated-serum-\u03b1-synuclein-autoantibodies-in-patients-with-parkinsons-disease-relative-to-alzheimers-disease-and-controls\/\" \/>\n<meta property=\"og:locale\" content=\"ar_AR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Elevated Serum \u03b1-Synuclein Autoantibodies in Patients with Parkinson\u2019s Disease - Menarah\" \/>\n<meta property=\"og:description\" content=\"Early diagnosis of neurodegenerative diseases is of paramount importance for successful treatment. Lack of sensitive and early biomarkers for diagnosis of diseases like Parkinson\u2019s disease (PD) is a handicapping problem for all movement disorders specialists. Using serum autoimmune antibodies (AIAs) against neural proteins is a new promising strategy to diagnose brain disorders through non-invasive and […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/menarah.org\/ar\/elevated-serum-\u03b1-synuclein-autoantibodies-in-patients-with-parkinsons-disease-relative-to-alzheimers-disease-and-controls\/\" \/>\n<meta property=\"og:site_name\" content=\"Menarah\" \/>\n<meta property=\"article:published_time\" content=\"2017-01-01T10:59:31+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-01-08T09:59:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/menarah.org\/wp-content\/uploads\/2020\/06\/Screenshot-2020-06-26-at-14.53.37.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1480\" \/>\n\t<meta property=\"og:image:height\" content=\"1048\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Dr. Mohamed Salama\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u0643\u064f\u062a\u0628 \u0628\u0648\u0627\u0633\u0637\u0629\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dr. Mohamed Salama\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u0648\u0642\u062a \u0627\u0644\u0642\u0631\u0627\u0621\u0629 \u0627\u0644\u0645\u064f\u0642\u062f\u0651\u0631\" \/>\n\t<meta name=\"twitter:data2\" content=\"\u062f\u0642\u064a\u0642\u0629 \u0648\u0627\u062d\u062f\u0629\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/menarah.org\\\/elevated-serum-%ce%b1-synuclein-autoantibodies-in-patients-with-parkinsons-disease-relative-to-alzheimers-disease-and-controls\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/menarah.org\\\/elevated-serum-%ce%b1-synuclein-autoantibodies-in-patients-with-parkinsons-disease-relative-to-alzheimers-disease-and-controls\\\/\"},\"author\":{\"name\":\"Dr. Mohamed Salama\",\"@id\":\"https:\\\/\\\/menarah.org\\\/#\\\/schema\\\/person\\\/31d8b4616fa7455ebb0b07916a647a77\"},\"headline\":\"Elevated Serum \u03b1-Synuclein Autoantibodies in Patients with Parkinson\u2019s Disease\",\"datePublished\":\"2017-01-01T10:59:31+00:00\",\"dateModified\":\"2024-01-08T09:59:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/menarah.org\\\/elevated-serum-%ce%b1-synuclein-autoantibodies-in-patients-with-parkinsons-disease-relative-to-alzheimers-disease-and-controls\\\/\"},\"wordCount\":187,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/menarah.org\\\/elevated-serum-%ce%b1-synuclein-autoantibodies-in-patients-with-parkinsons-disease-relative-to-alzheimers-disease-and-controls\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/menarah.org\\\/wp-content\\\/uploads\\\/2020\\\/06\\\/Screenshot-2020-06-26-at-14.53.37.png\",\"keywords\":[\"2017\",\"Ageing\",\"Dementia\",\"Health\",\"Research\"],\"articleSection\":[\"Learning from the International Experience\",\"Publications\"],\"inLanguage\":\"ar\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/menarah.org\\\/elevated-serum-%ce%b1-synuclein-autoantibodies-in-patients-with-parkinsons-disease-relative-to-alzheimers-disease-and-controls\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/menarah.org\\\/elevated-serum-%ce%b1-synuclein-autoantibodies-in-patients-with-parkinsons-disease-relative-to-alzheimers-disease-and-controls\\\/\",\"url\":\"https:\\\/\\\/menarah.org\\\/elevated-serum-%ce%b1-synuclein-autoantibodies-in-patients-with-parkinsons-disease-relative-to-alzheimers-disease-and-controls\\\/\",\"name\":\"Elevated Serum \u03b1-Synuclein Autoantibodies in Patients with Parkinson\u2019s Disease - Menarah\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/menarah.org\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/menarah.org\\\/elevated-serum-%ce%b1-synuclein-autoantibodies-in-patients-with-parkinsons-disease-relative-to-alzheimers-disease-and-controls\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/menarah.org\\\/elevated-serum-%ce%b1-synuclein-autoantibodies-in-patients-with-parkinsons-disease-relative-to-alzheimers-disease-and-controls\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/menarah.org\\\/wp-content\\\/uploads\\\/2020\\\/06\\\/Screenshot-2020-06-26-at-14.53.37.png\",\"datePublished\":\"2017-01-01T10:59:31+00:00\",\"dateModified\":\"2024-01-08T09:59:24+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/menarah.org\\\/#\\\/schema\\\/person\\\/31d8b4616fa7455ebb0b07916a647a77\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/menarah.org\\\/elevated-serum-%ce%b1-synuclein-autoantibodies-in-patients-with-parkinsons-disease-relative-to-alzheimers-disease-and-controls\\\/#breadcrumb\"},\"inLanguage\":\"ar\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/menarah.org\\\/elevated-serum-%ce%b1-synuclein-autoantibodies-in-patients-with-parkinsons-disease-relative-to-alzheimers-disease-and-controls\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ar\",\"@id\":\"https:\\\/\\\/menarah.org\\\/elevated-serum-%ce%b1-synuclein-autoantibodies-in-patients-with-parkinsons-disease-relative-to-alzheimers-disease-and-controls\\\/#primaryimage\",\"url\":\"https:\\\/\\\/menarah.org\\\/wp-content\\\/uploads\\\/2020\\\/06\\\/Screenshot-2020-06-26-at-14.53.37.png\",\"contentUrl\":\"https:\\\/\\\/menarah.org\\\/wp-content\\\/uploads\\\/2020\\\/06\\\/Screenshot-2020-06-26-at-14.53.37.png\",\"width\":1480,\"height\":1048},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/menarah.org\\\/elevated-serum-%ce%b1-synuclein-autoantibodies-in-patients-with-parkinsons-disease-relative-to-alzheimers-disease-and-controls\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/menarah.org\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Elevated Serum \u03b1-Synuclein Autoantibodies in Patients with Parkinson\u2019s Disease\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/menarah.org\\\/#website\",\"url\":\"https:\\\/\\\/menarah.org\\\/\",\"name\":\"Menarah\",\"description\":\"Middle East & North Africa Research on Ageing Healthy\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/menarah.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ar\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/menarah.org\\\/#\\\/schema\\\/person\\\/31d8b4616fa7455ebb0b07916a647a77\",\"name\":\"Dr. Mohamed Salama\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ar\",\"@id\":\"https:\\\/\\\/menarah.org\\\/wp-content\\\/uploads\\\/2020\\\/05\\\/M_Salama_photo-1.jpg\",\"url\":\"https:\\\/\\\/menarah.org\\\/wp-content\\\/uploads\\\/2020\\\/05\\\/M_Salama_photo-1.jpg\",\"contentUrl\":\"https:\\\/\\\/menarah.org\\\/wp-content\\\/uploads\\\/2020\\\/05\\\/M_Salama_photo-1.jpg\",\"caption\":\"Dr. Mohamed Salama\"},\"description\":\"Institute of Global Health and Human Ecology,\u00a0American University in Cairo, Egypt Dr Mohamed Salama established the first Translational Neuroscience Unit in Egypt. Mohamed\u2019s collaborative research led to establishing the Egyptian Network for Neurodegenerative Disorders (ENND). Mohamed was selected as a SOT Global Senior Scholar in 2013 and Translational\\\/bridging awardee in 2016. He was awarded by Parkinson\u2019s and Movement Disorders Foundation (PMDF) for his continuing research in the field of neurodegeneration. Recently, Mohamed and his colleagues succeeded to draft the first Reference Egyptian Genome\u00a0and collaborating with other colleagues to start a national cohort (A Longitudinal Study of Egyptian Health Aging [AL-SEHA]).\u00a0Currently, Mohamed is Atlantic senior fellow for Equity in brain health at the Global Brain Health Institute (GBHI) and Associate professor at the Institute of Global Health and Human Ecology at the American University in Cairo (AUC).\",\"url\":\"https:\\\/\\\/menarah.org\\\/ar\\\/author\\\/mohamedsalama\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u0627\u0631\u062a\u0641\u0627\u0639 \u0645\u0633\u062a\u0648\u0649 \u0627\u0644\u0623\u062c\u0633\u0627\u0645 \u0627\u0644\u0645\u0636\u0627\u062f\u0629 \u0627\u0644\u0630\u0627\u062a\u064a\u0629 \u0644\u0640 \u03b1-Synuclein \u0641\u064a \u0645\u0635\u0644 \u0627\u0644\u062f\u0645 \u0644\u062f\u0649 \u0645\u0631\u0636\u0649 \u0628\u0627\u0631\u0643\u0646\u0633\u0648\u0646 - \u0645\u0646\u0627\u0631\u0629","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/menarah.org\/ar\/elevated-serum-\u03b1-synuclein-autoantibodies-in-patients-with-parkinsons-disease-relative-to-alzheimers-disease-and-controls\/","og_locale":"ar_AR","og_type":"article","og_title":"Elevated Serum \u03b1-Synuclein Autoantibodies in Patients with Parkinson\u2019s Disease - Menarah","og_description":"Early diagnosis of neurodegenerative diseases is of paramount importance for successful treatment. Lack of sensitive and early biomarkers for diagnosis of diseases like Parkinson\u2019s disease (PD) is a handicapping problem for all movement disorders specialists. Using serum autoimmune antibodies (AIAs) against neural proteins is a new promising strategy to diagnose brain disorders through non-invasive and […]","og_url":"https:\/\/menarah.org\/ar\/elevated-serum-\u03b1-synuclein-autoantibodies-in-patients-with-parkinsons-disease-relative-to-alzheimers-disease-and-controls\/","og_site_name":"Menarah","article_published_time":"2017-01-01T10:59:31+00:00","article_modified_time":"2024-01-08T09:59:24+00:00","og_image":[{"width":1480,"height":1048,"url":"https:\/\/menarah.org\/wp-content\/uploads\/2020\/06\/Screenshot-2020-06-26-at-14.53.37.png","type":"image\/png"}],"author":"Dr. Mohamed Salama","twitter_card":"summary_large_image","twitter_misc":{"\u0643\u064f\u062a\u0628 \u0628\u0648\u0627\u0633\u0637\u0629":"Dr. Mohamed Salama","\u0648\u0642\u062a \u0627\u0644\u0642\u0631\u0627\u0621\u0629 \u0627\u0644\u0645\u064f\u0642\u062f\u0651\u0631":"\u062f\u0642\u064a\u0642\u0629 \u0648\u0627\u062d\u062f\u0629"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/menarah.org\/elevated-serum-%ce%b1-synuclein-autoantibodies-in-patients-with-parkinsons-disease-relative-to-alzheimers-disease-and-controls\/#article","isPartOf":{"@id":"https:\/\/menarah.org\/elevated-serum-%ce%b1-synuclein-autoantibodies-in-patients-with-parkinsons-disease-relative-to-alzheimers-disease-and-controls\/"},"author":{"name":"Dr. Mohamed Salama","@id":"https:\/\/menarah.org\/#\/schema\/person\/31d8b4616fa7455ebb0b07916a647a77"},"headline":"Elevated Serum \u03b1-Synuclein Autoantibodies in Patients with Parkinson\u2019s Disease","datePublished":"2017-01-01T10:59:31+00:00","dateModified":"2024-01-08T09:59:24+00:00","mainEntityOfPage":{"@id":"https:\/\/menarah.org\/elevated-serum-%ce%b1-synuclein-autoantibodies-in-patients-with-parkinsons-disease-relative-to-alzheimers-disease-and-controls\/"},"wordCount":187,"commentCount":0,"image":{"@id":"https:\/\/menarah.org\/elevated-serum-%ce%b1-synuclein-autoantibodies-in-patients-with-parkinsons-disease-relative-to-alzheimers-disease-and-controls\/#primaryimage"},"thumbnailUrl":"https:\/\/menarah.org\/wp-content\/uploads\/2020\/06\/Screenshot-2020-06-26-at-14.53.37.png","keywords":["2017","Ageing","Dementia","Health","Research"],"articleSection":["Learning from the International Experience","Publications"],"inLanguage":"ar","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/menarah.org\/elevated-serum-%ce%b1-synuclein-autoantibodies-in-patients-with-parkinsons-disease-relative-to-alzheimers-disease-and-controls\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/menarah.org\/elevated-serum-%ce%b1-synuclein-autoantibodies-in-patients-with-parkinsons-disease-relative-to-alzheimers-disease-and-controls\/","url":"https:\/\/menarah.org\/elevated-serum-%ce%b1-synuclein-autoantibodies-in-patients-with-parkinsons-disease-relative-to-alzheimers-disease-and-controls\/","name":"\u0627\u0631\u062a\u0641\u0627\u0639 \u0645\u0633\u062a\u0648\u0649 \u0627\u0644\u0623\u062c\u0633\u0627\u0645 \u0627\u0644\u0645\u0636\u0627\u062f\u0629 \u0627\u0644\u0630\u0627\u062a\u064a\u0629 \u0644\u0640 \u03b1-Synuclein \u0641\u064a \u0645\u0635\u0644 \u0627\u0644\u062f\u0645 \u0644\u062f\u0649 \u0645\u0631\u0636\u0649 \u0628\u0627\u0631\u0643\u0646\u0633\u0648\u0646 - \u0645\u0646\u0627\u0631\u0629","isPartOf":{"@id":"https:\/\/menarah.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/menarah.org\/elevated-serum-%ce%b1-synuclein-autoantibodies-in-patients-with-parkinsons-disease-relative-to-alzheimers-disease-and-controls\/#primaryimage"},"image":{"@id":"https:\/\/menarah.org\/elevated-serum-%ce%b1-synuclein-autoantibodies-in-patients-with-parkinsons-disease-relative-to-alzheimers-disease-and-controls\/#primaryimage"},"thumbnailUrl":"https:\/\/menarah.org\/wp-content\/uploads\/2020\/06\/Screenshot-2020-06-26-at-14.53.37.png","datePublished":"2017-01-01T10:59:31+00:00","dateModified":"2024-01-08T09:59:24+00:00","author":{"@id":"https:\/\/menarah.org\/#\/schema\/person\/31d8b4616fa7455ebb0b07916a647a77"},"breadcrumb":{"@id":"https:\/\/menarah.org\/elevated-serum-%ce%b1-synuclein-autoantibodies-in-patients-with-parkinsons-disease-relative-to-alzheimers-disease-and-controls\/#breadcrumb"},"inLanguage":"ar","potentialAction":[{"@type":"ReadAction","target":["https:\/\/menarah.org\/elevated-serum-%ce%b1-synuclein-autoantibodies-in-patients-with-parkinsons-disease-relative-to-alzheimers-disease-and-controls\/"]}]},{"@type":"ImageObject","inLanguage":"ar","@id":"https:\/\/menarah.org\/elevated-serum-%ce%b1-synuclein-autoantibodies-in-patients-with-parkinsons-disease-relative-to-alzheimers-disease-and-controls\/#primaryimage","url":"https:\/\/menarah.org\/wp-content\/uploads\/2020\/06\/Screenshot-2020-06-26-at-14.53.37.png","contentUrl":"https:\/\/menarah.org\/wp-content\/uploads\/2020\/06\/Screenshot-2020-06-26-at-14.53.37.png","width":1480,"height":1048},{"@type":"BreadcrumbList","@id":"https:\/\/menarah.org\/elevated-serum-%ce%b1-synuclein-autoantibodies-in-patients-with-parkinsons-disease-relative-to-alzheimers-disease-and-controls\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/menarah.org\/"},{"@type":"ListItem","position":2,"name":"Elevated Serum \u03b1-Synuclein Autoantibodies in Patients with Parkinson\u2019s Disease"}]},{"@type":"WebSite","@id":"https:\/\/menarah.org\/#website","url":"https:\/\/menarah.org\/","name":"\u0645\u0646\u0627\u0631\u0629","description":"\u0623\u0628\u062d\u0627\u062b \u0627\u0644\u0634\u0631\u0642 \u0627\u0644\u0623\u0648\u0633\u0637 \u0648\u0634\u0645\u0627\u0644 \u0623\u0641\u0631\u064a\u0642\u064a\u0627 \u062d\u0648\u0644 \u0627\u0644\u0634\u064a\u062e\u0648\u062e\u0629 \u0627\u0644\u0635\u062d\u064a\u0629","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/menarah.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ar"},{"@type":"Person","@id":"https:\/\/menarah.org\/#\/schema\/person\/31d8b4616fa7455ebb0b07916a647a77","name":"\u062f\u0643\u062a\u0648\u0631 \u0645\u062d\u0645\u062f \u0633\u0644\u0627\u0645\u0629","image":{"@type":"ImageObject","inLanguage":"ar","@id":"https:\/\/menarah.org\/wp-content\/uploads\/2020\/05\/M_Salama_photo-1.jpg","url":"https:\/\/menarah.org\/wp-content\/uploads\/2020\/05\/M_Salama_photo-1.jpg","contentUrl":"https:\/\/menarah.org\/wp-content\/uploads\/2020\/05\/M_Salama_photo-1.jpg","caption":"Dr. Mohamed Salama"},"description":"Institute of Global Health and Human Ecology,\u00a0American University in Cairo, Egypt Dr Mohamed Salama established the first Translational Neuroscience Unit in Egypt. Mohamed\u2019s collaborative research led to establishing the Egyptian Network for Neurodegenerative Disorders (ENND). Mohamed was selected as a SOT Global Senior Scholar in 2013 and Translational\/bridging awardee in 2016. He was awarded by Parkinson\u2019s and Movement Disorders Foundation (PMDF) for his continuing research in the field of neurodegeneration. Recently, Mohamed and his colleagues succeeded to draft the first Reference Egyptian Genome\u00a0and collaborating with other colleagues to start a national cohort (A Longitudinal Study of Egyptian Health Aging [AL-SEHA]).\u00a0Currently, Mohamed is Atlantic senior fellow for Equity in brain health at the Global Brain Health Institute (GBHI) and Associate professor at the Institute of Global Health and Human Ecology at the American University in Cairo (AUC).","url":"https:\/\/menarah.org\/ar\/author\/mohamedsalama\/"}]}},"featured_image_src":"https:\/\/menarah.org\/wp-content\/uploads\/2020\/06\/Screenshot-2020-06-26-at-14.53.37-600x400.png","featured_image_src_square":"https:\/\/menarah.org\/wp-content\/uploads\/2020\/06\/Screenshot-2020-06-26-at-14.53.37-600x600.png","author_info":{"display_name":"Dr. Mohamed Salama","author_link":"https:\/\/menarah.org\/ar\/author\/mohamedsalama\/"},"_links":{"self":[{"href":"https:\/\/menarah.org\/ar\/wp-json\/wp\/v2\/posts\/214","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/menarah.org\/ar\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/menarah.org\/ar\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/menarah.org\/ar\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/menarah.org\/ar\/wp-json\/wp\/v2\/comments?post=214"}],"version-history":[{"count":1,"href":"https:\/\/menarah.org\/ar\/wp-json\/wp\/v2\/posts\/214\/revisions"}],"predecessor-version":[{"id":1544,"href":"https:\/\/menarah.org\/ar\/wp-json\/wp\/v2\/posts\/214\/revisions\/1544"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/menarah.org\/ar\/wp-json\/wp\/v2\/media\/383"}],"wp:attachment":[{"href":"https:\/\/menarah.org\/ar\/wp-json\/wp\/v2\/media?parent=214"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/menarah.org\/ar\/wp-json\/wp\/v2\/categories?post=214"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/menarah.org\/ar\/wp-json\/wp\/v2\/tags?post=214"}],"curies":[{"name":"\u0648\u0648\u0631\u062f\u0628\u0631\u064a\u0633","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}